𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparison of in vitro hepatic models for the prediction of metabolic interaction between simvastatin and naringenin

✍ Scribed by N. Le Goff; J. C. Koffel; S. Vandenschrieck; L. Jung; G. Ubeaud


Publisher
Springer-Verlag
Year
2002
Tongue
English
Weight
980 KB
Volume
27
Category
Article
ISSN
0378-7966

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Predicting interactions between conventi
✍ John S. Markowitz; Lisa L. von Moltke; Jennifer L. Donovan πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 192 KB

## Abstract The potential for various natural products to perturb the metabolism and disposition of medications has been recognized for decades. There are numerous __in vitro__ and __in vivo__ methods available to screen botanical products for drug interaction potential. Although many normal volunt

Strategy for in vitro evaluation of the
✍ Dr. Denis Labarre; BΓ©atrice Montdargent; Marie-Paule Carreno; FranΓ§oise Maillet πŸ“‚ Article πŸ“… 1993 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 940 KB

Because of the importance of complement activation in the induced activation of leukocytes in vivo, determination of the complement-activating capacity of a candidate biomaterial is an important step in evaluating its biocompatibility. In vitro evaluation can be performed in the presence of human se

Prediction of plasma protein binding dis
✍ Hege Christensen; Mark Baker; Geoffrey T. Tucker; Amin Rostami-Hodjegan πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 231 KB πŸ‘ 1 views

Although displacement from plasma protein binding (dPB) is usually of little clinical significance, it should be taken into account when interpreting changes in total plasma concentrations of drugs subject to metabolically based drug-drug interactions (mDDI). The aim of this study was to develop an